Skip to content
Sign in
StableLaborReported 2026-11-19 13:00

Regulatory emergency order issued against Tokyo clinic for unapproved cell therapy

Japan's Ministry of Health, Labour and Welfare issued an emergency order under the Act on Safety of Regenerative Medicine, ordering Tokyo Clinic (ICVS) to halt provision of dendritic cell and activated lymphocyte therapy for advanced cancer after multiple severe disease cases were reported without required safety reports.

Why it matters. The order halts a specific unproven cell therapy being offered to cancer patients, highlighting regulatory oversight gaps and patient safety risks in the rapidly growing regenerative medicine sector.

01

Evidence

  • 厚厚生労働省Regulator2026-11-19 13:00
    今般、再生医療等情報提供・通報窓口への情報提供をもとに実施した調査を通じ、「医療法人社団ICVS 東京クリニック」(東京都千代田区。
    View source